Prostate cancer trials in United Kingdom
105 trials · From ClinicalTrials.gov, checked 14 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleThe PROSECCA Study, Answering New Questions in Prostate Cancer
- Where
- Edinburgh
- People
- 15,000
- Run by
- University of Edinburgh
See details and how to joinNCT06714630 - Phase 1/2Taking peopleA Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
- Where
- Bath, Leicester, London, Manchester, Oxford, Southampton, Sutton, Taunton
- Age
- 18 years and over
- People
- 300 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04104776 · EU 2023-508002-20-00 - Phase 1/2Taking peopleTT-702 in Patients With Advanced Solid Tumours.
- Where
- London, Manchester, Southampton
- Age
- 16 years and over
- People
- 60
- Run by
- Cancer Research UK
See details and how to joinNCT05272709 - No phaseTaking peoplePatient and Provider Perspectives on Genetic Risk Profiling
- Where
- London
- Age
- 18 years to 100 years
- People
- 40
- Run by
- Royal Marsden NHS Foundation Trust
See details and how to joinNCT07741929 - No phaseTaking peopleSpaceOAR Post-Market Registry Study
- Where
- Derby, Liverpool, London, Maidstone, Norwich
- Age
- 18 years and over
- People
- 320 worldwide
- Run by
- Sheffield Teaching Hospitals NHS Foundation Trust
See details and how to joinNCT07300631 - No phaseTaking peopleBeSpoke Decision Support for Patients With Newly Diagnosed Localised Prostate Cancer
- Where
- London
- People
- 346
- Run by
- University College, London
See details and how to joinNCT07135271 - Phase 1Taking peopleStudy of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
- Where
- London, Manchester, Newcastle upon Tyne
- Age
- 18 years and over
- People
- 220 worldwide
- Run by
- MOMA Therapeutics
See details and how to joinNCT06545942 - No phaseNot yet taking people in United KingdomResistance Exercise, IL-7 and Immune Phenotypes in Prostate Cancer
- Where
- Bath
- Age
- 18 years and over
- People
- 40
- Run by
- University of Bath
See details and how to joinNCT07724080 - Phase 3Taking peopleThe Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global)
- Where
- London, Windsor
- Age
- 18 years and over
- People
- 520 worldwide
- Run by
- Telix Pharmaceuticals (Innovations) Pty Limited
See details and how to joinNCT06520345 - Phase 1Taking peopleStudy of ORIC-944 in Patients With Metastatic Prostate Cancer
- Where
- Sutton
- Age
- 18 years and over
- People
- 275 worldwide
- Run by
- ORIC Pharmaceuticals
See details and how to joinNCT05413421 · EU 2024-515527-11-00 - No phaseTaking peopleRobotic Prostatectomy Artificial Intelligence Low Pressure Pain (RALP) Trial
- Where
- Stevenage
- Age
- 18 years to 75 years
- People
- 100
- Run by
- East and North Hertfordshire NHS Trust
See details and how to joinNCT06915909 - Phase 1Taking peopleFirst-in-human Study of 225Ac-PSMA-Trillium (BAY 3563254) in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC)
- Where
- London, Newcastle upon Tyne, Sutton
- Age
- 18 years and over
- People
- 198 worldwide
- Run by
- Bayer
See details and how to joinNCT06217822 · EU 2023-507486-26-00 - Phase 2Taking peopleINSPIRE: INnovative SABR for Prostate Cancer All IREland
- Where
- Belfast
- Age
- 18 years and over
- People
- 136 worldwide
- Run by
- Cancer Trials Ireland
See details and how to joinNCT07552168 - Phase 4Taking peopleLong-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
- Where
- Barnet, Cambridge, Glasgow, Middlesbrough, Sutton
- Age
- 18 years to 100 years
- People
- 700 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT05803941 · EU 2023-503208-94-00 - No phaseTaking peopleTrans and Non-binary Prostate-Specific Antigen Reference Interval Determination Study
- Where
- London
- Age
- 40 years to 100 years
- People
- 500
- Run by
- Queen Mary University of London
See details and how to joinNCT06987045 - No phaseTaking peopleInternational Registry for Men With Advanced Prostate Cancer (IRONMAN)
- Where
- Cardiff, Lancaster, London, Manchester, Metropolitan Borough of Wirral, Northwood, Preston, Sheffield, Southampton, South Shields, Stevenage, Sunderland
- Age
- 21 years and over
- People
- 5,000 worldwide
- Run by
- Prostate Cancer Clinical Trials Consortium
See details and how to joinNCT03151629 - Phase 1Taking peopleA Study of DS9051b in Participants With Advanced or Metastatic Adrenocortical Carcinoma and Metastatic Castration-resistant Prostate Cancer
- Where
- London
- Age
- 18 years and over
- People
- 40 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT07189403 · EU 2025-521886-28-00 - No phaseTaking peopleEVERiST: Impact of Image Detected Accessory Pudendal Artery on Erection Recovery After Nerve Sparing Prostatectomy
- Where
- London
- Age
- 18 years to 79 years
- People
- 40
- Run by
- University College, London
See details and how to joinNCT07597798 - No phaseTaking peopleA Study to Evaluate the Performance of Confocal Microscopy to Detect Positive Margins During Radical Prostatectomy
- Where
- London
- Age
- 18 years and over
- People
- 693
- Run by
- University College, London
See details and how to joinNCT07541911 - Phase 1/2Taking peopleAnti-tumour Activity of (177Lu) rhPSMA-10.1 Injection
- Where
- Bristol, Glasgow, London, Middlesbrough, Oxford, Sheffield, Southampton
- Age
- 18 years and over
- People
- 82 worldwide
- Run by
- Blue Earth Therapeutics Ltd
See details and how to joinNCT05413850 · EU 2024-511537-35-00 - No phaseTaking peopleSelecting Hypoxic Tumours for Treatment Modification
- Where
- Manchester
- Age
- 18 years and over
- People
- 30
- Run by
- University of Manchester
See details and how to joinNCT06787053 - Phase 1/2Taking peopleACTinium in Castrate-RESistant Prostate Cancer After LUTEtium
- Where
- London
- Age
- 18 years and over
- People
- 60
- Run by
- University College, London
See details and how to joinNCT07414940 - Phase 1/2Taking peopleClinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
- Where
- London
- Age
- 18 years and over
- People
- 66 worldwide
- Run by
- SpectraCure AB
See details and how to joinNCT03067051 - Phase 1/2Taking peopleGedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer
- Where
- Cambridge, Southampton, Sutton
- Age
- 18 years and over
- People
- 54 worldwide
- Run by
- Celcuity Inc
See details and how to joinNCT06190899 · EU 2023-505898-32-00 - No phaseTaking peopleImperial Prostate 9 - ATLAS (Approaches To Long-Term Active Surveillance)
- Where
- Ascot, Bradford, Chertsey, Dartford, London, Newcastle upon Tyne, Rhyl, Scunthorpe, Southampton, Whitehaven
- Age
- 18 years and over
- People
- 1,263
- Run by
- Imperial College London
See details and how to joinNCT06280781